The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysis
Conclusions
S-1 is effective and tolerable as first-line therapy for advanced gastric cancer in both Asian and Western countries.
Source: Gastric Cancer - Category: Gastroenterology Source Type: research
More News: Cancer | Cancer & Oncology | Clinical Trials | Gastric (Stomach) Cancer | Gastroenterology | Study | Toxicology | Xeloda